Lutetium-177 PSMA-617
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for Lutetium-177 PSMA-617, covering 2019-11-14 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer [Phase 1]